tiprankstipranks
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Cash flow

Compare
2,206 Followers

BioCryst Cash Flow

BCRX's free cash flow for Q3 2024 was $8.19M. For the 2024 fiscal year, BCRX's free cash flow was decreased by $65.89M and operating cash flow was $8.24M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -95.14M$ -161.85M$ -142.16M$ -137.22M$ -89.58M
Investing Cash Flow
$ -131.50M$ -128.24M$ 15.80M$ -6.86M$ 77.93M
Financing Cash Flow
$ 32.48M$ 88.03M$ 359.67M$ 302.70M$ 99.10M
End Cash Position
$ 112.45M$ 306.24M$ 507.73M$ 274.35M$ 115.72M
Free Cash Flow
$ -97.31M$ -163.20M$ -144.54M$ -137.73M$ -89.93M
Currency in USD

BioCryst Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis